CVI Holdings’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

CVI Holdings’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,401,640	Closed	-$3.74M	–	70
2019 Q2	$3.74M	Buy	+1,401,640	New	+$5.04M	4.32%	6

Other funds holding SRNE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CVI Holdings's SRNE Position: Q3 2019 in Review

CVI Holdings sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2019, closing a stake of 1,401,640 shares — an estimated $3.74M sold.

CVI Holdings first reported a position in SRNE in Q2 2019 and held it in 1 quarter. The position peaked at $3.74M in Q2 2019. 85 funds tracked by Wall St. Rank hold SRNE as of Q3 2019.

CVI Holdings reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
CVI Holdings sold 1,401,640 Sorrento Therapeutics, Inc. shares in Q3 2019, an estimated $3.74M.
CVI Holdings first reported a position in Sorrento Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
CVI Holdings's Sorrento Therapeutics, Inc. position peaked at $3.74M in Q2 2019.
85 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2019.

Based on CVI Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.